Baxter International [BAX] vs Repligen [RGEN] Detailed Stock Comparison

Baxter International Inc.

NYSE
Loading...

Repligen Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Baxter International Inc. wins in 11 metrics, Repligen Corporation wins in 9 metrics, with 0 ties. Baxter International Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Baxter International Inc. Repligen Corporation Better
P/E Ratio (TTM) 86.31 154.30 Baxter International Inc.
Price-to-Book Ratio 1.54 3.55 Baxter International Inc.
Debt-to-Equity Ratio 160.28 32.76 Repligen Corporation
PEG Ratio 0.73 -1.10 Baxter International Inc.
EV/EBITDA 8.55 59.13 Baxter International Inc.
Profit Margin (TTM) -8.51% 6.62% Repligen Corporation
Operating Margin (TTM) 7.36% 8.26% Repligen Corporation
EBITDA Margin (TTM) 7.36% 8.26% Repligen Corporation
Return on Equity -13.71% 2.40% Repligen Corporation
Return on Assets (TTM) 2.83% 0.99% Baxter International Inc.
Free Cash Flow (TTM) $323.00M $91.69M Baxter International Inc.
Dividend Yield 1.77% N/A N/A
1-Year Return -31.87% 2.41% Repligen Corporation
Price-to-Sales Ratio (TTM) 0.85 10.14 Baxter International Inc.
Enterprise Value $17.26B $7.36B Baxter International Inc.
EV/Revenue Ratio 1.54 9.97 Baxter International Inc.
Gross Profit Margin (TTM) 19.40% 52.46% Repligen Corporation
Revenue per Share (TTM) $22 $13 Baxter International Inc.
Earnings per Share (Diluted) $-1.75 $0.86 Repligen Corporation
Beta (Stock Volatility) 0.62 1.19 Baxter International Inc.
Short % of Float 12.33% 9.88% Repligen Corporation

Baxter International Inc. vs Repligen Corporation Stock Performance Analysis

Loading Price Chart...

BAX
RGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Baxter International Inc.-0.24%8.16%20.29%21.84%6.55%6.72%
Repligen Corporation0.21%4.42%27.22%13.69%-18.50%-20.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Baxter International Inc.-31.87%-54.01%-74.19%-53.06%-34.17%1.07%
Repligen Corporation2.41%-17.06%-33.82%517.16%3,568.26%4,563.93%

Performance & Financial Health Analysis: Baxter International Inc. vs Repligen Corporation

MetricBAXRGEN
Market Information
Market Cap i$9.38B$7.49B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i6,387,585734,741
90 Day Avg. Volume i7,931,785871,350
Last Close$20.81$130.87
52 Week Range$15.73 - $31.76$100.99 - $175.77
% from 52W High-34.48%-25.54%
All-Time High$95.19 (Apr 20, 2020)$327.32 (Sep 20, 2021)
% from All-Time High-78.14%-60.02%
Growth Metrics
Quarterly Revenue Growth0.08%0.18%
Quarterly Earnings Growth0.08%0.18%
Financial Health
Profit Margin (TTM) i-0.09%0.07%
Operating Margin (TTM) i0.07%0.08%
Return on Equity (TTM) i-0.14%0.02%
Debt to Equity (MRQ) i160.2832.76
Cash & Liquidity
Book Value per Share (MRQ)$11.92$37.39
Cash per Share (MRQ)$3.82$13.63
Operating Cash Flow (TTM) i$845.00M$117.42M
Levered Free Cash Flow (TTM) i$2.43B$76.07M
Dividends
Last 12-Month Dividend Yield i1.77%N/A
Last 12-Month Dividend i$0.36N/A

Valuation & Enterprise Metrics Analysis: Baxter International Inc. vs Repligen Corporation

MetricBAX (Apr 26, 2026)RGEN (Apr 21, 2026)
Price Ratios
P/E Ratio (TTM) i86.31154.30
Forward P/E i9.0952.71
PEG Ratio i0.73-1.10
Price to Sales (TTM) i0.8510.14
Price to Book (MRQ) i1.543.55
Market Capitalization
Market Capitalization i$9.38B$7.49B
Enterprise Value i$17.26B$7.36B
Enterprise Value Metrics
Enterprise to Revenue i1.549.97
Enterprise to EBITDA i8.5559.13
Risk & Other Metrics
Beta i0.621.19
Book Value per Share (MRQ) i$11.92$37.39

Financial Statements Comparison: Baxter International Inc. vs Repligen Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBAX (2025)RGEN (2025)
Revenue/Sales i11.24B738.26M
Cost of Goods Sold i7.87B352.01M
COGS % of Revenue i69.9%47.7%
Gross Profit i3.38B386.25M
Gross Margin i30.1%52.3%
Research & Development i518.00M54.18M
Operating Income (EBIT) i177.00M41.56M
Operating Margin i1.6%5.6%
EBITDA i1.26B139.67M
EBITDA Margin i11.2%18.9%
Pre-Tax Income i-505.00M62.38M
Pre-Tax Income % of Revenue i-4.5%8.5%
Income Tax i395.00M13.49M
Income Tax % of Revenue i3.5%1.8%
Net Income (Profit) i-957.00M48.89M
Profit Margin i-8.5%6.6%

Balance Sheet & Liquidity Metrics

MetricBAX (2025)RGEN (2025)
Cash & Equivalents i1.97B566.02M
Total Current Assets i6.87B1.14B
Total Current Assets % of Revenue i61.1%154.1%
Total Current Liabilities i2.97B135.83M
Total Current Liabilities % of Revenue i26.4%18.4%
Long-Term Debt i9.70B668.39M
Long-Term Debt % of Revenue i86.2%90.5%
Total Shareholders Equity i6.10B2.11B
Retained Earnings i13.71B456.25M
Retained Earnings % of Revenue i121.9%61.8%
Property, Plant & Equipment i651.00M267.49M

Cash Flow Statement Comparison

MetricBAX (2025)RGEN (2025)
Operating Cash Flow i-24.00M113.36M
Operating Cash Flow % of Revenue i-0.2%15.4%
Capital Expenditures iN/A-23.28M
Free Cash Flow i323.00M91.69M
FCF Margin i2.9%12.4%
Debt Repayment i-5.79B0
Common Stock Repurchase iN/A0

Short Interest & Institutional Ownership Analysis

MetricBAXRGEN
Shares Short i40.31M5.56M
Short Ratio i4.116.38
Short % of Float i12.33%9.88%
Shares Outstanding i514.28M56.33M
Float Shares i512.05M53.30M
% Held by Insiders i0.32%5.29%
% Held by Institutions i109.89%112.70%
% Held by Public i-10.21%-17.99%

Dividend Analysis & Yield Comparison: Baxter International Inc. vs Repligen Corporation

MetricBAXRGEN
Last 12-Month Dividend i$0.36N/A
Last 12-Month Dividend Yield i1.77%N/A
3-Year Avg Annual Dividend i$0.81N/A
3-Year Avg Dividend Yield i0.57%N/A
3-Year Total Dividends i$2.44N/A
Ex-Dividend DateFeb 27, 2026N/A